These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 8302193

  • 1. [Treatment of insomnia related to depressive disorders. Effects of zolpidem versus flunitrazepam administration and withdrawal evaluated in a double-blind study].
    Guazzelli M, Ciapparelli A, Balsamo EL, Gemignani A, Sarteschi P.
    Minerva Psichiatr; 1993 Sep; 34(3):193-203. PubMed ID: 8302193
    [Abstract] [Full Text] [Related]

  • 2. Double blind comparison of zolpidem 20 mg versus flunitrazepam 2 mg in insomniac in-patients.
    Frattola L, Maggioni M, Cesana B, Priore P.
    Drugs Exp Clin Res; 1990 Sep; 16(7):371-6. PubMed ID: 2092963
    [Abstract] [Full Text] [Related]

  • 3. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
    Fava M, Asnis GM, Shrivastava RK, Lydiard B, Bastani B, Sheehan DV, Roth T.
    J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
    [Abstract] [Full Text] [Related]

  • 4. Effects of zolpidem and flunitrazepam on nocturnal sleep of women subjectively complaining of insomnia.
    Declerck AC, Ruwe F, O'Hanlon JF, Vermeeren A, Wauquier A.
    Psychopharmacology (Berl); 1992 Jul; 106(4):497-501. PubMed ID: 1579623
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
    Roth T, Soubrane C, Titeux L, Walsh JK, Zoladult Study Group.
    Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
    [Abstract] [Full Text] [Related]

  • 6. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.
    Elie R, Rüther E, Farr I, Emilien G, Salinas E.
    J Clin Psychiatry; 1999 Aug; 60(8):536-44. PubMed ID: 10485636
    [Abstract] [Full Text] [Related]

  • 7. Zolpidem for persistent insomnia in SSRI-treated depressed patients.
    Asnis GM, Chakraburtty A, DuBoff EA, Krystal A, Londborg PD, Rosenberg R, Roth-Schechter B, Scharf MB, Walsh JK.
    J Clin Psychiatry; 1999 Oct; 60(10):668-76. PubMed ID: 10549683
    [Abstract] [Full Text] [Related]

  • 8. Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset following spontaneous middle-of-the-night awakening in insomnia in a randomized, double-blind, placebo-controlled, outpatient study.
    Roth T, Krystal A, Steinberg FJ, Singh NN, Moline M.
    Sleep; 2013 Feb 01; 36(2):189-96. PubMed ID: 23372266
    [Abstract] [Full Text] [Related]

  • 9. Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study.
    Krystal AD, Erman M, Zammit GK, Soubrane C, Roth T, ZOLONG Study Group.
    Sleep; 2008 Jan 01; 31(1):79-90. PubMed ID: 18220081
    [Abstract] [Full Text] [Related]

  • 10. Gender Differences in the Efficacy and Safety of Chronic Nightly Zolpidem.
    Roehrs TA, Roth T.
    J Clin Sleep Med; 2016 Mar 01; 12(3):319-25. PubMed ID: 26446253
    [Abstract] [Full Text] [Related]

  • 11. Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia.
    Perlis ML, McCall WV, Krystal AD, Walsh JK.
    J Clin Psychiatry; 2004 Aug 01; 65(8):1128-37. PubMed ID: 15323600
    [Abstract] [Full Text] [Related]

  • 12. Zolpidem and rebound insomnia--a double-blind, controlled polysomnographic study in chronic insomniac patients.
    Monti JM, Attali P, Monti D, Zipfel A, de la Giclais B, Morselli PL.
    Pharmacopsychiatry; 1994 Jul 01; 27(4):166-75. PubMed ID: 7972349
    [Abstract] [Full Text] [Related]

  • 13. A double-blind, comparative study of zolpidem and placebo in the treatment of insomnia in elderly psychiatric in-patients.
    Shaw SH, Curson H, Coquelin JP.
    J Int Med Res; 1992 Apr 01; 20(2):150-61. PubMed ID: 1521671
    [Abstract] [Full Text] [Related]

  • 14. Pilot controlled double-blind study of the hypnotic effects of zolpidem in patients with chronic 'learned' insomnia: psychometric and polysomnographic evaluation.
    Herrmann WM, Kubicki ST, Boden S, Eich FX, Attali P, Coquelin JP.
    J Int Med Res; 1993 Apr 01; 21(6):306-22. PubMed ID: 8143886
    [Abstract] [Full Text] [Related]

  • 15. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
    Saletu B, Saletu-Zyhlarz G, Anderer P, Brandstätter N, Frey R, Gruber G, Klösch G, Mandl M, Grünberger J, Linzmayer L.
    Neuropsychobiology; 1997 Apr 01; 36(3):130-52. PubMed ID: 9313245
    [Abstract] [Full Text] [Related]

  • 16. Zolpidem extended-release improves sleep and next-day symptoms in comorbid insomnia and generalized anxiety disorder.
    Fava M, Asnis GM, Shrivastava R, Lydiard B, Bastani B, Sheehan D, Roth T.
    J Clin Psychopharmacol; 2009 Jun 01; 29(3):222-30. PubMed ID: 19440075
    [Abstract] [Full Text] [Related]

  • 17. Multicenter, double-blind, controlled comparison of zolpidem and triazolam in elderly patients with insomnia.
    Roger M, Attali P, Coquelin JP.
    Clin Ther; 1993 Jun 01; 15(1):127-36. PubMed ID: 8458042
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of almorexant in adult chronic insomnia: a randomized placebo-controlled trial with an active reference.
    Black J, Pillar G, Hedner J, Polo O, Berkani O, Mangialaio S, Hmissi A, Zammit G, Hajak G.
    Sleep Med; 2017 Aug 01; 36():86-94. PubMed ID: 28735928
    [Abstract] [Full Text] [Related]

  • 19. Zolpidem in the treatment of short-term insomnia: a randomized, double-blind, placebo-controlled clinical trial.
    Dockhorn RJ, Dockhorn DW.
    Clin Neuropharmacol; 1996 Aug 01; 19(4):333-40. PubMed ID: 8828996
    [Abstract] [Full Text] [Related]

  • 20. A 2-week efficacy and safety study of gaboxadol and zolpidem using electronic diaries in primary insomnia outpatients.
    Hajak G, Hedner J, Eglin M, Loft H, Stórustovu SI, Lütolf S, Lundahl J, Gaboxadol Study 99775 Group.
    Sleep Med; 2009 Aug 01; 10(7):705-12. PubMed ID: 19346160
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.